Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RAS Lifesciences is an Indian molecular diagnostics company that specializes in the development and manufacture of PCR-based diagnostic kits. Based in Hyderabad, the company offers a comprehensive portfolio of products for the detection and quantification of infectious diseases, including HIV, HBV, and HCV, as well as solutions for oncology and genetic testing. In 2012, the company was acquired by Bio-Rad Laboratories, which integrated RAS's capabilities to strengthen its diagnostic offerings in emerging markets. RAS Lifesciences continues to operate as a key manufacturing and R&D hub for molecular diagnostics within the Bio-Rad group. Its products are designed to provide high sensitivity and specificity for clinical laboratories and hospitals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RAS Lifesciences.